Waissi, W.; Amé, J.-C.; Mura, C.; Noël, G.; Burckel, H.
Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. Int. J. Mol. Sci. 2021, 22, 6825.
https://doi.org/10.3390/ijms22136825
AMA Style
Waissi W, Amé J-C, Mura C, Noël G, Burckel H.
Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. International Journal of Molecular Sciences. 2021; 22(13):6825.
https://doi.org/10.3390/ijms22136825
Chicago/Turabian Style
Waissi, Waisse, Jean-Christophe Amé, Carole Mura, Georges Noël, and Hélène Burckel.
2021. "Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines" International Journal of Molecular Sciences 22, no. 13: 6825.
https://doi.org/10.3390/ijms22136825
APA Style
Waissi, W., Amé, J.-C., Mura, C., Noël, G., & Burckel, H.
(2021). Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. International Journal of Molecular Sciences, 22(13), 6825.
https://doi.org/10.3390/ijms22136825